rs756928158
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000361726.7(GJB1):c.271G>A(p.Val91Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V91G) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000361726.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GJB1 | NM_000166.6 | c.271G>A | p.Val91Met | missense_variant | 2/2 | ENST00000361726.7 | NP_000157.1 | |
GJB1 | NM_001097642.3 | c.271G>A | p.Val91Met | missense_variant | 2/2 | NP_001091111.1 | ||
GJB1 | XM_011530907.3 | c.271G>A | p.Val91Met | missense_variant | 2/2 | XP_011529209.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GJB1 | ENST00000361726.7 | c.271G>A | p.Val91Met | missense_variant | 2/2 | 1 | NM_000166.6 | ENSP00000354900 | P1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 02, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2018 | - - |
Charcot-Marie-Tooth disease X-linked dominant 1 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University Hospital Muenster | Jun 10, 2022 | ACMG categories: PS3,PM1,PM2,PP3,PP5 - |
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Dec 13, 2019 | The GJB1 c.271G>A (p.Val91Met) variant is a missense variant that has been reported in a heterozygous state in at least eight individuals with Charcot-Marie-Tooth neuropathy (Bissar-Tadmouri et al. 2000; Dobourg et al. 2001; Michelle et al. 2009; Arthur-Farraj et al. 2012; Tsai et al. 2016; Hong et al. 2017). Affected individuals presented with motor neuropathy, areflexia, ataxia, paresthesia of the feet, numbness and/or weakness of lower limbs, and sensorineural hearing loss in at least one affected individual. Age of onset was variable, but generally occurred in the first or second decade. The p.Val91Met variant was absent from 50 control individuals (Dobourg et al. 2001) and is not found in the Genome Aggregation Database despite good sequence coverage, so the variant is presumed to be rare. Functional studies in HeLa cells showed decreased expression of the p.Val91Met variant protein in the plasma membrane compared to controls (Tsai et al. 2016). In addition, the variant protein was mainly localized to the cytoplasm and showed fewer gap junction plaques at the intercellular boundaries compared to wild-type. Additional tests were conducted in HEK293T cells where Ca2+ signaling propagation was evaluated. Impaired gap junction permeability was observed and the onset-to-peak duration of the signal was longer in cells expressing the p.Val91Met variant compared to those expressing wild-type protein (Tsai et al. 2016). The p.Val91Met variant is located in the second transmembrane domain which is suggested to be important for protein conformation. Based on the collective evidence, the p.Val91Met variant is classified as pathogenic for Charcot-Marie-Tooth neuropathy X type 1. - |
Charcot-Marie-Tooth Neuropathy X Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2023 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 91 of the GJB1 protein (p.Val91Met). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with CMTX (PMID: 11140841, 11571214, 22464564, 27027447, 27844031, 28097225). ClinVar contains an entry for this variant (Variation ID: 195025). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GJB1 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at